5348042025-04-012025-06-305348042025-04-012025-06-30in-capmkt:OtherExpenses1Member5348042025-04-012025-06-30

ItemsThatWillNotBeReclassifiedToProfitAndLoss1

iso4217:INRiso4217:INRxbrli:shares

534804

CARERATING

INE752H01013

CARE RATINGS LIMITED

Main Board

Equity

2025-04-01

2026-03-31

2025-08-05

2025-07-23

INR

Lakhs

Quarterly

First quarter

Single segment

Rating Business & Others

2025-08-05

12:15:00

2025-08-05

16:00:00

Not applicable

false

2025-04-01

2025-06-30

Unaudited

Standalone

756393000

147447000

903840000

397321000

4116000

20936000

87717000

510090000

393750000

97419000

5176000

102595000

291155000

-2734000

288421000

299581000

9.72

9.67

9.72

9.67

The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on August 05, 2025 and have been subjected to limited review by the statutory auditors of the Company. The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended from time to time) read with section 133 of the Companies Act, 2013. During Q1 FY 25-26, the Company granted 7,500 options to eligible employees of the Group under the Company's Employees Stock Option Scheme (ESOS) 2020 which are duly approved by shareholders in Annual General Meeting and Nomination and Remuneration Committee. The Company has alloted 25,933 equity shares of Rs.10 each pursuant to excercise of employee stock options during Q1 FY 25-26. As per Ind AS 102 - Share Based Payment, total cost of ESOS 2020 is recognised over vesting period. Employee Benefit Expenses in Standalone results includes ESOP charge for June 30 2025 is Rs. 35.19 The figures for the quarter ended March 31, 2025 in the above financial results are the balancing figures between the audited figures for the full previous financial year ended March 31, 2025 and the year to date unaudited limited reviewed figures published up to the nine months ended December 31, 2024.

Other Expenses

87717000

Items that will not be reclassified to profit and loss

-3654000

-920000

-2734000